Funding
Funding not disclosed
Founders
Product
Problem
Current bioadhesives often lack the biocompatibility and strength required for effective tissue engineering and biomedical applications. Traditional adhesives can also introduce toxicity or fail to provide a strong, lasting bond in wet biological environments.
Solution
Kollodis BioSciences develops and supplies bioadhesives based on mussel adhesive proteins (MAPs), offering superior biocompatibility and adhesion strength compared to conventional options. These MAP-based adhesives mimic the natural bonding mechanisms of mussels, providing robust adhesion in wet and dynamic biological conditions. Kollodis' products are designed to facilitate tissue engineering, wound closure, and other biomedical research and development applications, promoting improved outcomes and reduced complications. The bioadhesives are available in various formulations and kits to meet diverse application needs.
Target Audience
The primary target audience includes researchers, biomedical engineers, and product developers in the fields of tissue engineering, regenerative medicine, and medical device development.
Features
- Mussel adhesive protein-based formulation for enhanced biocompatibility and adhesion
- Strong and durable bonding in wet biological environments
- Customizable formulations to suit specific tissue types and applications
- Available in various formats, including liquid adhesives and pre-coated substrates
- Suitable for tissue engineering, wound closure, and biomedical research